What 21 CFR Part 111 Actually Requires for Raw Material Identity Testing—And Why Most Supplement Brands Fall Short

FDA warning letters citing §111.75 violations don’t typically land because a manufacturer was deliberately cutting corners. They land because the gap between “our analytical laboratory tests everything” and “we comply with 21 CFR Part 111” is wider than most quality managers realize—until an inspector is standing at their receiving dock asking to see method validation records. Failures in incoming component testing, and botanical identity testing in particular, have consistently ranked among the most cited violations in dietary supplement warning letters. That pattern isn’t an accident. It’s the predictable result of regulations that are stricter than they look on first read.

At our Chicago receiving facility, we see the full range of what brands are actually doing before they ship us a sample for third-party confirmation. Some arrive with rigorous written specifications and orthogonal testing protocols already in place. Others send a kilogram of powdered botanical with a sticky note that reads “supplier COA attached.” The second group is almost never in compliance. Here’s a precise explanation of why—and what fixing it actually requires.

The Actual Language in §111.75—And Why Botanicals Get Special Treatment

21 CFR §111.75 governs what a manufacturer must do before using any component in dietary supplement manufacturing. For most ingredient categories, the standard is relatively flexible: conduct at least one “appropriate test or examination” to verify identity. A validated NIR spectroscopy method, a documented wet chemistry screen, or a well-controlled organoleptic protocol can each satisfy this requirement for non-botanical components.

Botanical dietary ingredients carry a higher bar. §111.75(a)(1)(ii) states:

“You must use a scientifically valid method to conduct at least one identity test on each lot of every botanical dietary ingredient.”

Three phrases in that sentence carry enormous compliance weight. Scientifically valid method means the FDA has explicitly rejected organoleptic inspection alone—color, odor, texture, taste—as sufficient for botanicals. It can be part of a method. It cannot be the whole method. Each lot means every individual lot received, not each supplier, not each calendar quarter, not each shipment from a trusted vendor. And every botanical dietary ingredient means there are no carve-outs for simple herbs, no exceptions for ingredients with a long documented purchase history from a single supplier, and no category of botanical raw material that escapes the requirement.

That last point is where experienced quality teams get tripped up. A supplier you’ve purchased from for eight years can still ship you a mislabeled, adulterated, or substituted lot. Supply chains are not static—harvesting contractors change, processing facilities change, storage conditions vary by season. The regulation doesn’t account for the quality of your supplier relationship. Neither does a class action plaintiff’s attorney.

It’s also worth noting that §111.75(c) addresses whether you can substitute a supplier’s COA for required testing. The short answer is: not for botanical identity. Even under a formal supplier qualification program with documented periodic reconfirmation testing, the lot-by-lot identity testing requirement remains. A COA tells you what the supplier found when they tested their product. It says nothing about what arrived at your dock.

What Analytical Laboratories Use to Verify Botanical Identity: HPTLC, DNA, and Beyond

The FDA has not published a mandatory approved-methods list for botanical identity, which creates flexibility and confusion in roughly equal measure. In practice, the analytical laboratory community—and the USP botanical monographs—have converged on a core set of approaches, each with specific strengths and appropriate use cases.

HPTLC (High-Performance Thin-Layer Chromatography) is the backbone of compliant botanical identity testing for most raw materials. The American Herbal Pharmacopoeia and the USP Dietary Supplement Compendium contain validated HPTLC methods for hundreds of botanical ingredients, with published reference fingerprints and documented pass/fail criteria. HPTLC generates a chemical fingerprint—a pattern of bands corresponding to the marker compounds characteristic of a given species and plant part—that can distinguish Echinacea purpurea from Echinacea angustifolia, confirm the correct plant part (root vs. aerial vs. seed), and flag common adulterant species. For most botanical raw materials, a validated HPTLC method run against a certified reference standard and a documented reference fingerprint is the minimum credible identity test.

DNA Barcoding is particularly powerful for highly processed powders and extracts where the chemical profile may be degraded by extraction temperature, drying, or milling. The ITS2 and rbcL genetic markers are the most widely applied in botanical authentication. A 2013 study published in BMC Medicine analyzed 44 herbal products from 12 companies and found that 59% contained plant species not listed on the label—substitution, contamination with unlabeled species, or replacement with cheap fillers. That figure is frequently cited in regulatory discussions because it empirically illustrates the failure mode §111.75 was written to address. DNA barcoding is especially defensible when combined with HPTLC because the two methods operate on different dimensions of the ingredient—genetic identity vs. chemical composition—and address different adulteration strategies.

NIR and Raman Spectroscopy can serve as efficient incoming screening tools once you’ve built a validated reference library. The critical limitation is that these methods require significant upfront investment in authenticated reference materials and extensive validation documentation. Without a clearly documented library derived from botanically confirmed reference standards, an NIR result is difficult to defend in an FDA 483 response.

Microscopic Identification (addressed in USP <563>) uses cellular structures—starch granules, trichomes, vascular tissue, fiber morphology—as identifiers. These features survive processing better than volatile compounds and provide a layer of authentication that complements chemical methods. Used in isolation it’s rarely sufficient; used as part of a documented multi-method approach it adds meaningful documentation depth.

The practical standard our team applies for most botanical raw materials is a two-method orthogonal approach: validated HPTLC plus either DNA barcoding or microscopy, depending on the processing state of the material. For powders or extracts where DNA fragmentation is likely, HPTLC with mass spectral confirmation of key marker compounds is typically more reliable than barcoding alone.

The Five Most Common Compliance Failures We See at Incoming Receiving

Based on what arrives at our Chicago facility and what gets flagged during subsequent analytical testing, five failure modes appear with enough regularity that they’re worth naming directly.

1. The supplier COA treated as an identity test. This is the most common and most easily corrected gap. A supplier’s COA documents what the supplier found when they tested their material. It does not document what arrived at your dock. Under §111.75(c), a COA can reduce but not eliminate your testing obligation, and only under a formal documented supplier qualification program—not informally, and not for botanical identity regardless of supplier status.

2. Skip-lot testing applied to the identity requirement. Skip-lot sampling is a statistically valid approach for some incoming component attributes like moisture content or particle size. It does not apply to the §111.75 identity requirement. “Each lot” is explicit. Applying a skip-lot protocol to identity testing is a documented §111.75 violation waiting to be written up.

3. Undocumented or unvalidated methods. Having a trained technician perform an organoleptic check or run a quick TLC without a documented, validated SOP—including reference materials used, instrument parameters, acceptance criteria, and qualification records for the analyst—leaves you unable to demonstrate that the method is “scientifically valid” under the regulation’s terms. The method documentation is as important as the method itself. An FDA inspector reviewing your records will treat an undocumented method as no method.

4. Identity testing conducted on finished product rather than on incoming components. Some manufacturers pull finished product samples for identity confirmation after blending. §111.75 governs components before use. Finished product testing is valuable for other compliance purposes, but it doesn’t satisfy the incoming identity testing requirement. You need a documented result before the ingredient enters your manufacturing process.

5. No written component specifications. §111.70(b) requires written specifications for each component used in manufacturing. You cannot test against a specification that doesn’t exist. If your ashwagandha root powder specification doesn’t define the expected HPTLC fingerprint, acceptable withanolide range by HPLC, and absence of specific adulterant species—there’s nothing to compare your identity test result against. A test without defined acceptance criteria isn’t a test; it’s a data point with no compliance value.

Building a Compliant Raw Material Testing Program: Five Practical Steps

If your current program has gaps, the sequence below reflects how we walk Midwest supplement brands through building a defensible incoming testing system.

Step 1: Audit every botanical ingredient in your formulas. List every botanical dietary ingredient across your entire product portfolio. For each, document what identity test is currently in place for incoming lots, the analytical method used, whether that method is validated and documented, and whether it constitutes a “scientifically valid method” under §111.75. Gaps will be apparent quickly.

Step 2: Source or develop validated methods. For most commercially significant botanicals—ashwagandha, elderberry, echinacea, turmeric, valerian, ginkgo—validated HPTLC methods exist in the USP Dietary Supplement Compendium or the American Herbal Pharmacopoeia. These are ready to implement with appropriate reference standards. For less common botanicals or proprietary ingredient blends, method development and validation are required. An ISO 17025-accredited analytical laboratory can develop and validate a method under documented conditions that will withstand regulatory scrutiny.

Step 3: Establish authenticated reference standards. A validated method is only as strong as the reference material it’s run against. USP botanical reference standards are available for many species; for others, a certified reference material from a supplier with documented botanical identity chain-of-custody is required. Reference standard documentation—species confirmation, plant part, lot number, expiration, storage conditions—must be retained as part of your method records.

Step 4: Write complete component specifications. Every botanical ingredient needs a written specification that defines identity (species, chemotype where relevant, plant part), purity parameters, and contaminant limits including heavy metals per USP <232>/<233> and microbial limits per USP <2021>. The specification creates the acceptance criteria your identity test is evaluated against. Without it, test results have no compliance context.

Step 5: Build your documentation and retention infrastructure. Under 21 CFR §111.260, testing records must be retained for one year beyond the product’s shelf life, or two years from the date of manufacture, whichever is longer. Every lot-level identity test needs a record that captures the method used, the reference standard lot, the analyst, the instrument, the raw data, and the pass/fail determination signed by a qualified individual. That record is what you hand an FDA investigator when they ask to see your incoming testing documentation.

This is genuine infrastructure work. For brands starting from scratch across 15 or 20 botanical ingredients, it takes time to build correctly. But the investment pays back measurably the first time it catches a misidentified lot before it goes into 50,000 capsules—and prevents the much larger cost of a recall, a warning letter, or a product liability claim.

If you’re building or auditing your raw material testing program, start with your highest-volume botanicals and your highest-risk suppliers—those sourcing from regions with documented adulteration histories. Get those methods and specifications right, run them consistently, and build outward from there. Compliance here isn’t about passing audits. It’s about knowing exactly what’s in every kilogram of raw material you put into a product with your name on it.

---

Written by Nour Abochama, VP Operations, Qalitex | Quality Consultant, Ayah Labs. Learn more about our team

Ship your sample to our Chicago facility — get a Qalitex CoA in 5–7 days. Contact us

Related from our network

• ISO 17025-Accredited Supplement Testing at Qalitex Laboratories — California-based analytical laboratory providing HPTLC, DNA barcoding, ICP-MS, and full USP-compliant testing for dietary ingredient manufacturers.